Lyft to Announce Second Quarter 2025 Financial Results
On the same day, Lyft will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results and business highlights. To listen to the live audio webcast, please visit the Company's Investor Relations page at https://investor.lyft.com/.
The archived webcast will be available on the Company's Investor Relations page shortly after the call.
Lyft announces material information to the public about the Company, its products and services and other matters through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, webcasts, the investor relations section of its website (investor.lyft.com), its X accounts (including: @lyft, @davidrisher), its Chief Executive Officer's LinkedIn account (linkedin.com/in/jdavidrisher), and its blogs (including: lyft.com/blog, lyft.com/hub, and eng.lyft.com) in order to achieve broad, non-exclusionary distribution of information to the public and to comply with its disclosure obligations under Regulation FD.
About Lyft
Whether it's an everyday commute or a journey that changes everything, Lyft is driven by our purpose: to serve and connect. In 2012, Lyft was founded as one of the first ridesharing communities in the United States. Now, millions of drivers have chosen to earn on billions of rides. Lyft offers rideshare, bikes, and scooters all in one app — for a more connected world, with transportation for everyone.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
DEER PARK, Ill., July 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ('Eton' or the 'Company') (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Dial In: (800) 715-9871 or (646) 307-1963; Conference ID: 5899895 Webcast: Click Here In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@ live webcast can also be accessed on the Investors section of Eton's website at An archived webcast will be available on Eton's website approximately two hours after the completion of the event and for 30 days thereafter. About Eton Pharmaceuticals Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia®, ET-700, ET-800 and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at Investor Relations: Lisa M. WilsonIn-Site Communications, Inc.T: 212-452-2793E: lwilson@ Source: Eton Pharmaceuticals, Inc.
Forbes
7 minutes ago
- Forbes
Sell Merck Stock Ahead Of Its Upcoming Earnings?
CHONGQING, CHINA - JULY 27: In this photo illustration, a person holds a smartphone displaying the ... More logo of Merck & Co., Inc. (NYSE: MRK), a leading American multinational pharmaceutical company, with the company's iconic green and white emblem visible in the background, on July 27, 2025 in Chongqing, China. (Photo illustration by) Merck (NYSE:MRK) is set to reveal its earnings on Tuesday, July 29, 2025. Historically, MRK stock has exhibited a trend of negative one-day returns following earnings announcements. In the past five years, the stock saw a decline on the day following earnings in 60% of occurrences. The median one-day drop was -2.1%, with the largest single-day decrease reaching -9.8%. Although the actual results relative to consensus estimates will be significant, recognizing these historical patterns can give an edge to event-driven traders. There are two main strategies to utilize this information: Analysts anticipate earnings of $2.03 per share on revenue of $15.87 billion for the forthcoming quarter. This indicates a slight reduction compared to the earnings of $2.28 per share on sales of $16.11 billion from the same quarter last year. This expected decrease in sales is primarily due to ongoing difficulties faced by Gardasil in China, despite the continued growth in Keytruda sales. Additionally, see – Merck's Keytruda Dependency: A Growth Story With An Expiration Date. From a fundamental viewpoint, Merck currently has a market capitalization of approximately $212 billion. Over the past twelve months, the company generated $64 billion in revenue, and was operationally profitable with $20 billion in operating profits and a net income of $17 billion. That being said, if you are looking for upside with lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having outperformed the S&P 500 and produced returns exceeding 91% since its inception. View earnings reaction history of all stocks Merck's Historical Odds Of Positive Post-Earnings Return Insights on one-day (1D) post-earnings returns: Additional data for the observed 5-Day (5D) and 21-Day (21D) returns post earnings are summarized along with the statistics in the table below. MRK 1D, 5D, and 21D Post Earnings Return Correlation Between 1D, 5D, and 21D Historical Returns A relatively low-risk strategy (though not beneficial if the correlation is weak) is to understand the relationship between short-term and medium-term returns after earnings, identify a pair with the highest correlation, and execute the suitable trade. For instance, if 1D and 5D exhibit the strongest correlation, a trader can position themselves 'long' for the next 5 days if the 1D post-earnings return is positive. Here is some correlation data based on 5-year and more recent 3-year history. Note that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and subsequent 5D returns. MRK Correlation Between 1D, 5D and 21D Historical Returns Is There Any Correlation With Peer Earnings? Occasionally, the performance of peers can influence the post-earnings reaction of stocks. In fact, the pricing-in might start ahead of the earnings announcement. Below is some historical data comparing Merck's post-earnings performance with that of peers who reported earnings just prior to Merck. For a fair comparison, peer stock returns also represent post-earnings one-day (1D) returns. MRK Correlation With Peer Earnings Find out more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all 3, the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns for investors. Alternatively, if you desire upside with a smoother experience than an individual stock like Merck, consider the High Quality portfolio, which has surpassed the S&P, achieving >91% returns since inception.
Business Wire
8 minutes ago
- Business Wire
Perion Announces Participation in Leading Investor Conferences in August and September 2025
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today announced its participation in the following upcoming investor conferences: Canaccord Genuity 45 th Annual Growth Conference Boston, August 12 Fireside chat with Perion's CEO, Tal Jacobson at 8:00am ET Watch live webcast: Oppenheimer 28 th Annual Technology, Internet & Communications Conference Virtual, August 13 Fireside chat with Perion's CEO, Tal Jacobson at 9:55am ET Watch live webcast: Lake Street Best Ideas Growth (BIG 9) Conference on September 11th in New York Tal Jacobson, CEO, and Elad Tzubey, CFO, will host one-on-one meetings with investors. To request a meeting, please contact your representatives at Canaccord Genuity, Oppenheimer, or Lake Street Capital Markets. About Perion Network Ltd. Perion is helping agencies, brands and retailers get better results with their marketing investments by providing advanced technology across digital channels. Through the Perion One platform, we are making digital advertising more effective by building solutions that continuously adapt to connect the dots between data, creative and channels. For more information, visit Perion's website at
